Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer? – Lombardi Comprehensive Cancer Center
For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells more responsive to immunotherapy. The research is now in a phase 2 clinical trial being tested in human patients.